US Broker Ratings

Chemed Corp (CHE) Stock Analysis: Exploring a Potential Upside of Nearly 28%

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, specifically within the medical care facilities industry, commands investor attention with its diverse service offerings and promising financial outlook...

Edwards Lifesciences Corporation (EW) Stock Analysis: A 17.45% Upside Potential with Robust Growth Prospects

Edwards Lifesciences Corporation (EW), a leading player in the healthcare sector, specifically within the medical devices industry, presents a compelling investment opportunity for those looking to capitalize on its innovative..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: Exploring a 17% Upside in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical company, is gaining significant attention from investors with its focus on rare neuroendocrine diseases and a promising potential upside of 17.11%. The..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring an 80.94% Potential Upside in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) is a standout player in the medical devices industry, focusing on innovative solutions for obstructive sleep apnea (OSA). With a market capitalization of $2.36..

ADMA Biologics Inc (ADMA) Stock Analysis: 82.65% Potential Upside Ignites Investor Interest

ADMA Biologics Inc (ADMA), a key player in the biotechnology sector, is capturing significant attention from investors, fueled by a notable potential upside of 82.65%. As a company dedicated to..

Cardinal Health, Inc. (CAH) Stock Analysis: Evaluating a 20.85% Potential Upside in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a key player in the healthcare sector, offers a compelling opportunity for investors, with analysts predicting a potential upside of 20.85%. With a substantial market..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 37.46% Potential Upside Amidst a Tumultuous Market

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a beacon of innovation in the biotechnology sector, with its focus on RNA-targeted therapeutics and gene therapies for rare diseases. As a commercial-stage..

Boston Scientific Corporation (BSX) Stock Analysis: Promising 27% Upside Potential Amid Robust Growth

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector, particularly within the medical devices industry, is capturing investor attention with a market capitalization of $144.96 billion and..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a Potential 1.98% Upside in the Pharmaceutical Space

Dr. Reddy’s Laboratories Ltd (RDY) stands as a formidable player in the global pharmaceutical industry, with a notable presence in North America, Europe, India, and Russia. With a market capitalization..

Encompass Health Corporation (EHC): Investor Outlook on a Healthcare Leader with a 10.77% Upside Potential

For those keen on the healthcare sector, Encompass Health Corporation (NYSE: EHC) presents a compelling investment opportunity. With a market capitalization of $12.5 billion, this Birmingham, Alabama-based giant stands as..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unlocking a Potential 234.91% Upside in Biotechnology

Vaxcyte, Inc. (NASDAQ: PCVX), a burgeoning player in the biotechnology sector, has captured the attention of investors with its ambitious pipeline of vaccine candidates aimed at tackling bacterial infectious diseases...

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 51.8% Potential Upside in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL), a rising star in the biotechnology sector, is capturing the attention of investors with its innovative approach to cancer treatment. Headquartered in Cambridge, Massachusetts, this clinical-stage..

Humana Inc. (HUM) Stock Analysis: Exploring an 18% Potential Upside Amid Healthcare Sector Dynamics

For investors eyeing the healthcare sector, Humana Inc. (NYSE: HUM) presents a compelling case with its diversified offerings and solid market position. As a major player in the healthcare plans..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring Growth Potential and Analyst Ratings

HCA Healthcare, Inc. (NYSE: HCA) stands as a significant player in the healthcare sector, particularly within the medical care facilities industry in the United States. With a market capitalization of..

Merit Medical Systems, Inc. (MMSI): Investor Outlook on Growth Potential and Analyst Consensus

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $4.95 billion, the company..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 32.68% Potential Upside Amidst Robust Revenue Growth

Investors looking for opportunities in the healthcare sector may want to turn their attention to Intuitive Surgical, Inc. (NASDAQ: ISRG), a leading innovator in the medical instruments and supplies industry...

ICON plc (ICLR) Investor Outlook: Navigating Volatility with a 23.95% Potential Upside

Investors looking for opportunities in the healthcare sector may find ICON plc (NASDAQ: ICLR) an intriguing candidate. The company, headquartered in Dublin, Ireland, is a global leader in providing outsourced..

Masimo Corporation (MASI) Stock Analysis: Exploring a 33.57% Potential Upside for Investors

Masimo Corporation (MASI), a prominent player in the healthcare sector, continues to capture investor attention with its innovative contributions to the medical devices industry. Headquartered in Irvine, California, Masimo is..

Biogen Inc. (BIIB) Stock Analysis: Unpacking a 19% Upside Potential Amidst Healthcare Innovation

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, continues to intrigue investors with its innovative approach to neurological and neurodegenerative disease treatments. With a market capitalization of $20.89..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Healthcare Leader Faces Mixed Signals Amidst Market Volatility

Investors with a keen eye on the healthcare sector might find Bausch + Lomb Corporation (NYSE: BLCO) intriguing, particularly given its longstanding reputation in the eye health industry. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds